StemGen, Inc.
SGNI · OTC
6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -6.64 | 2.67 | 0.01 | -23.46 |
| FCF Yield | -0.31% | -0.10% | -0.41% | -0.05% |
| EV / EBITDA | -256.65 | -773.75 | -143.33 | 164.33 |
| Quality | ||||
| ROIC | 31.65% | 6.99% | 79.26% | 9.39% |
| Gross Margin | 21.91% | 55.70% | 61.42% | 0.00% |
| Cash Conversion Ratio | 0.33 | 0.16 | 0.25 | -1.33 |
| Growth | ||||
| Revenue 3-Year CAGR | 20.92% | – | – | – |
| Free Cash Flow Growth | -286.57% | 65.24% | -1,191.84% | -207.79% |
| Safety | ||||
| Net Debt / EBITDA | -3.12 | -11.80 | -3.06 | 5.73 |
| Interest Coverage | -1.73 | -0.48 | -4.23 | -0.35 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | -0.46 | 0.00 | 0.00 |
| Cash Conversion Cycle | -2,024.45 | -8,580.04 | -7,698.37 | 0.00 |